TYMP and neoplasm: Oral capecitabine generates 5-fluorouracil (5-FU) preferentially in tumour tissue by exploitation of the increased activity of thymidine phosphorylase (TP) in tumour compared with normal tissue (Miwa et al, 1998; Schüller et al, 2000).